|
HS Code |
432727 |
| Name | 8-Aminoquinaldine |
| Chemical Formula | C10H10N2 |
| Molecular Weight | 158.20 g/mol |
| Cas Number | 578-18-1 |
| Appearance | Pale yellow to light brown solid |
| Melting Point | 79-82°C |
| Boiling Point | 344°C |
| Solubility In Water | Slightly soluble |
| Density | 1.19 g/cm3 |
| Purity | Typically ≥98% |
| Storage Temperature | Room temperature |
| Pka | 5.35 (amino group) |
| Flash Point | 156°C |
| Inchi Key | ZKSMLTKBKUOYJF-UHFFFAOYSA-N |
| Smiles | Cc1ccc2ccnc(N)c2c1 |
As an accredited 8-Aminoquinaldine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | 8-Aminoquinaldine is packaged in a 25g amber glass bottle with a screw cap and safety label detailing hazard information. |
| Shipping | 8-Aminoquinaldine is shipped in tightly sealed containers under ambient temperature, protected from moisture and incompatible materials. It is classified as a hazardous chemical and must be handled and transported according to regulatory standards, including appropriate labeling and documentation, to ensure safety during transit and upon receipt by authorized laboratories or facilities. |
| Storage | 8-Aminoquinaldine should be stored in a tightly closed container in a cool, dry, and well-ventilated area, away from sources of ignition, heat, and incompatible substances such as strong oxidizers. Protect it from moisture and direct sunlight. Properly label the container and keep it in designated chemical storage areas, following all relevant safety protocols and local regulations. |
Applications of 8-Aminoquinaldine in Industrial ManufacturingAs an established manufacturer of 8-Aminoquinaldine, we serve sectors that require reliable, quality-controlled intermediates and building blocks in their downstream synthesis. Below we highlight verified industrial application scenarios where this raw material is integral to core formulations and production methods. Each scenario details industry compliance, accepted formulation ratios, integration in production lines, and corresponding end products, based on industry-acknowledged data and our manufacturer experience. 1. Pharmaceutical Synthesis: Active Pharmaceutical Ingredient (API) Intermediate8-Aminoquinaldine is a key intermediate for synthesis of various quinoline-derivative APIs, especially in anti-malarial, anti-tuberculosis, and CNS-active pharmaceutical ingredients. Downstream pharmaceutical houses integrate this material early in multistep organic syntheses, ensuring traceability and controlled impurity profiles to meet audit requirements. As the intermediate is converted into advanced intermediates, monitoring content and purity during the condensation or cyclization stage remains critical for yield and regulatory inspection. Final APIs are stringently validated for route-specific residuals and genesis. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Agrochemical Intermediate ManufacturingDownstream agrochemical manufacturers employ 8-Aminoquinaldine as a critical structural precursor in synthesizing select herbicides and crop-protection active compounds, leveraging its ability to accept diverse side-chain modifications. Compliance involves pesticide regulations as well as in-process analytical control to verify compliance with maximum impurity thresholds at both intermediate and final product stages. Typically, synthesis batches are closely monitored for precursor conversion rates to ensure that residuals meet regulatory expectations prior to final formulation. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Colorant and Dye Intermediate ProductionIndustrial dye and pigment companies selectively employ 8-Aminoquinaldine to synthesize specialty colorant intermediates, particularly for high-performance azo and anthraquinone dyes where amino quinoline rings produce unique shades and fastness properties. Process controls ensure that raw material addition corresponds with desired chromophore formation while accounting for batch-to-batch purity and color consistency. Quality requirements specify residual amine and related contaminants, governed by sector-specific ecological safety criteria. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Analytical Reagent ManufacturingProducers of laboratory and field analytical kits utilize 8-Aminoquinaldine as a specific derivatization reagent or indicator, especially in chelation and spectrophotometric analysis of transition metals. Downstream applications demand pharmaceutical/analytical purity grades and strict batch release criteria to guarantee reagent stability and reduce analytical background. Integration focuses on controlled dissolution and reaction environments for consistent performance in final detection systems. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive 8-Aminoquinaldine prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
As a chemical manufacturer, every decision around production reflects years of work in the lab, on the plant floor, and in close communication with chemists in industries from pharmaceuticals to fine chemicals. Introducing 8-aminoquinaldine is not simply an expansion of our catalog but the result of direct observations about what modern synthetic chemistry requires. In our experience, reliable access to well-characterized heterocycles shapes the success of both research and commercial production. Over the years, 8-aminoquinaldine has found a strong following among scientists looking for a scaffold that combines manageable reactivity with practical solubility and stability.
8-Aminoquinaldine (2-methyl-8-aminquinoline) carries the formula C10H10N2. Thanks to the methyl substitution on the quinoline core, 8-aminoquinaldine stands out from other aminated heterocycles, especially for researchers concerned with reaction predictability and selectivity. We’ve watched chemists return to this molecule because of the unique way it balances nucleophilicity and steric effects across a variety of coupling and substitution reactions. Where unsubstituted aminoquinoline or aniline analogs introduce uncertainty in process outcomes, 8-aminoquinaldine brings a reliable mix of electronic effects that allow more finely tuned synthetic planning, especially for those seeking alternatives to legacy heterocycles that too easily generate byproducts.
Our facility produces 8-aminoquinaldine with a purity level that meets stringent expectations for pharmaceutical intermediates and advanced materials. Crystallization controls and quality checks ensure that residual solvent levels and trace metal content land within narrow, consistently measured tolerances. Reliable batch homogeneity and repeatable melting behavior matter just as much to us as they do to anyone who understands that a failed run can take weeks out of a project timeline. Chromatographic profiles reveal batch-to-batch consistency, and we opt for transparency—supplying full analytical reports and answering any process-related queries directly.
8-Aminoquinaldine joins a focused set of quinoline derivatives that feature not only in ligands and chiral auxiliaries, but also act as building blocks for antimalarial drug discovery, dye intermediates, and specialty material precursors. In our own conversations with process chemists, the need for a reagent that offers predictable reactivity at the 8-position—while tolerating common electrophilic and nucleophilic conditions—emerges as a constant theme.
Pharmaceutical synthesis often demands scaffolds that hold up under aggressive stepwise transformations. 8-Aminoquinaldine’s resilience and selective reactivity have led to its adoption in a range of substitution and cyclization protocols that frequently fail with more labile analogs. Other suppliers may focus on speed, but our approach puts weight on reproducibility. Project managers in both medicinal and process chemistry have stressed that minimizing load failures and purification headaches on scale is more important than shaving a day off delivery. For this reason, we spend resources maintaining the precise ratios of starting materials and monitoring each batch for polymorph variability.
On the technical side, we’ve recognized that 8-aminoquinaldine dissolves predictably in common organic solvents—especially ethanol, dichloromethane, and acetonitrile—making it easy to integrate into workflow operations that use standard glass or steel process vessels. Moisture has less impact on stability compared to similar amine-bearing aromatic compounds, which allows for slightly broader handling conditions in pilot plants.
Feedback from our network of bench chemists, analytical specialists, and production managers has consistently confirmed 8-aminoquinaldine as a problem solver in iterative synthesis design. Researchers working on kinase inhibitor libraries appreciate its unique electronic environment, which facilitates regioselective modifications. Those in pigment and dye manufacturing have mentioned that its stability aids in predictable color development and batch reproducibility, reducing the occurrence of unwanted tints that can disrupt quality control.
One recurring observation is how 8-aminoquinaldine enables scalable, low-temperature couplings and condensations with functionalized aryl halides, where other amines either decompose or generate inseparable side products. Industrial chemists balancing throughput and yield tell us that the combination of cost, supply consistency, and technical support keeps projects on schedule—even at volumes that challenge less robust supply chains.
While half a dozen aminated quinoline variants exist, many fall short on either stability or specificity. For example, 6-aminoquinolines sometimes show excess reactivity at unintended positions. 8-aminoquinaldine’s additional methyl group helps direct further functionalization, cutting down on unnecessary purification steps. We’ve documented, for example, that cyclization yields see measurable improvement versus non-methylated versions, with less tar and fewer colored side products, especially under scale-up conditions.
To be clear, other manufacturers may offer cheaper versions that cut corners on batch quality and impurity profiling. Experience tells us that cutting cost at the expense of characterization usually backfires—especially in regulated sectors. Project timelines quickly stretch when mystery impurities surface during pilot validation or final batch release. Our process emphasizes deep analytical validation from starting materials through finished packaged product, with impurity profiling by HPLC and NMR shared with clients on request.
The manufacturing strategy behind our 8-aminoquinaldine diverges from large-scale commodity synthesis to focus on reliability and technical dialogue. We maintain closer links with customers’ development teams, exchanging not just data but practical synthesis tips and troubleshooting guidance drawn from our own pilot experience. This knowledge transfer, based on real production runs, speeds up process transfer and supports researchers pushing boundaries in both medicinal chemistry and industrial reagent development.
From an operational perspective, downstream compatibility matters as much as upstream purity. 8-Aminoquinaldine translates smoothly into many synthetic sequences, including amide couplings, reductive aminations, and multi-component assembly. Its crystallinity makes for predictable filtration and drying, lowering the risk of clogs, slow filtration rates, or variable throughput during workup. This property receives almost no attention in catalogs, yet in the real world, it means bench and plant staff spend less time dealing with paste or tar formation.
Chemists value being able to move from milligram-scale SAR exploration all the way to hundred-kilo runs with only marginal process tweaking. Because we synchronize production planning with feedback cycles from R&D and process development customers, we can anticipate likely scale-up pitfalls and offer tailored guidance. For instance, subtle differences in impurity carryover—often minute enough to miss in early analytical screening—have an outsized effect on catalytic reactions and crystallization outcomes in development programs. Our experience allows us to flag and resolve these challenges as early as possible.
Beyond synthesis, our technical group keeps track of regulatory trends, especially as they affect raw material traceability and documentation. Many of our pharma customers want assurance that key starting materials can be sourced reliably for multi-year projects. Years of complying with such documentation builds the institutional memory that larger, less focused suppliers frequently lack. By integrating these practices, we reduce the headache factor for regulatory submission teams.
Consistency in product quality begins with sourcing, flows through process control, and shows up as on-spec product in clients’ hands. Our experience proves that small variations—especially in precursor quality—ripple through entire product lines, creating trouble that only reveals itself at the most inconvenient moments. For this reason, our operators and QA teams work from validated raw material sources and invest in detailed incoming inspection. A decade ago, we learned the hard way that failing to standardize precursor lots compromised whole production campaigns; we haven’t made that mistake since.
Our process incorporates automated documentation for every critical control point, while physical samples from every lot enter a retained library in case clients ever need reference for troubleshooting or root-cause investigations. This meticulous practice, more often found in pharmaceutical production than bulk chemicals, ultimately protects downstream partners from unexpected issues. It’s this sort of detail that explains not just repeat business, but direct technical collaboration with leading synthesis development companies.
Securing the right amount of any advanced intermediate poses long-term supply questions. We’ve seen the havoc caused by supply disruptions or last-minute specification shifts. Customers tell us plainly that promises matter less than demonstrated supply continuity. We base our 8-aminoquinaldine production around scheduled forecasts, regular stock rotation, and flexible batch runs that absorb the inevitable fluctuations in demand without scrambling for stock at the last minute.
Technical assistance forms a core part of our offering, not just an afterthought. Our staff answer application questions, discuss process modifications, and share know-how accumulated over real-world campaigns. It’s common for clients to call us directly to trade notes on equipment fouling, filtration speeds, or reaction troubleshooting. We prefer open lines of communication, both for practical troubleshooting and strategic planning—something that document-driven vendors and disconnected megaproviders rarely match.
Working in close proximity to all stages of chemical production sharpens our focus on safety and environmental responsibilities. Handling aromatic amines calls for strict protocols—engineered systems, operator training, and responsible waste management, all rooted in years of best practice. From segregated storage of raw and finished materials, to contained transfer operations and continuous air monitoring, every detail of our plant design and daily routine aligns with the principle of protecting both workers and community. Transparent reporting and audit trails come standard, not as afterthoughts.
On the environmental front, we’ve minimized waste and solvent use by recycling streamlines, solvent recovery programs, and switching to less hazardous reagents where synthesis permits. Our investments in closed-loop solvent systems reduce both operational cost and emissions footprint—a decision shaped by years of reviewing process audits and environmental incidents at other facilities. As scrutiny increases from stakeholders and regulators, our commitment to auditing and continuous improvement becomes a business advantage, not just a compliance necessity.
For every batch of 8-aminoquinaldine that leaves our plant, there’s not just a catalog number, but a history of sustained collaboration with customers and deep process insight. Years of feedback, troubleshooting, and shared victories with research partners underpin our confidence in this material. In the world of fine and specialty chemicals, technical edge comes from lived experience: knowing which properties truly matter over time, responding to the unexpected, and keeping one foot in both experimental design and day-to-day production reality.
8-Aminoquinaldine integrates a unique blend of physical, chemical, and operational strengths that support discovery and process teams with real-world needs. Our commitment goes beyond bulk supply—offering continuous dialogue, transparency, and technical support to help navigate both known requirements and future challenges. It is this approach that not only keeps projects moving but leads to better, more reliable outcomes for innovative chemical applications.